title: Does the public think it is reasonable to wait for more evidence before funding innovative health technologies? The case of PET scanning in Ontario.
abstract: OBJECTIVE
  Many innovative health technologies do not have a sufficient evidence-base to allow for adequate assessment of their benefits. Funders in several countries have been exploring arrangements that allow for temporary or partial coverage of these technologies, but only as part of a further evaluation. The public's support of arrangements that restrict access to innovative technology until sufficient evidence is available is crucial if these arrangements are going to remain viable. The project's other objective is to examine the lay public's views on a case in which patients' publicly funded access to an innovative health technology is being delayed until there is sufficient evidence to justify a coverage decision. The case considered is the Ontario (Canada) government's decision to restrict access to positron emission tomography (PET) scans until further evidence becomes available.
  
  
  METHODS
  The case was deliberated on by twenty-six members of the Toronto Health Policy Citizens' Council, with a follow-up survey administered to individual council members.
  
  
  RESULTS
  The majority of council members agreed that the approach taken by the government was reasonable and in the best interests of its citizens. The council did express concerns regarding certain aspects of the case, including about the length of time it is taking to obtain further evidence.
  
  
  CONCLUSIONS
  Public support for arrangements that limit access to new technologies will likely vary depending on the details of the specific arrangement being proposed. Deliberative public dialogue can be effectively used to identify cases the general public is most likely to support.
authors.affiliation: Cancer Services and Policy Research Unit, Cancer Care Ontario, Toronto, Ontario, Canada. roger.chafe@cancercare.on.ca
authors.forename: Roger
authors.initials: R
authors.lastname: Chafe
authors.forename: Farhan
authors.initials: F
authors.lastname: Merali
authors.forename: Andreas
authors.initials: A
authors.lastname: Laupacis
authors.forename: Wendy
authors.initials: W
authors.lastname: Levinson
authors.forename: Doug
authors.initials: D
authors.lastname: Martin
mesh_terms: D019317:Evidence-Based Medicine; D005380:Financing, Government; D009864:Ontario; D019982:Organizational Case Studies; D049268:Positron-Emission Tomography / Q000191:economics*; D013673:Technology Assessment, Biomedical